Found 265 matching trials
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
PHASE1This pilot clinical trial studies the side effects and best dose of ruxolit...
Location
City of Hope Medical Center
Allo HSCT Using RIC for Hematological Diseases
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
COVID Protection After Transplant-Immunosuppression Reduction
PHASE2This study will enroll individuals who have:
* Completed primary series of...
Location
University of California, San Diego
Busulfan and Cyclophosphamide Followed By ALLO BMT
NAThis is a treatment guideline to allow routine clinical data to be collecte...
Location
Masonic Cancer Center, University of Minnesota
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
PHASE1Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
NAThis study evaluates the addition of "Kidney Solid Organ Rejection Test" (k...
Location
National Institute of Medical Sciences and Health Salvador Zubiran
Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
PHASE4The purpose of this study is to understand the effects of everolimus on tac...
Location
National Taiwan University Hospital
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
PHASE2RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Location
Children's Memorial Hospital
Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus
PHASE4In this study we compare long term renal function in liver transplantation ...
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
PHASE1The goal of this clinical research study is to learn if it is safe and feas...
Location
University of Texas MD Anderson Cancer Center